GlassScriptPhysician profile
Katherine Elizabeth Teeter
NPI 1063161628
$886.65
in general payments reported to CMS, 2019-2025
18 companies · $15.53 in 2025
The $15.53 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $221 · 2023: $330 · 2024: $319 · 2025: $15.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.52 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $174.07 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $116.25 | 2022-2023 | |
| Shield Therapeutics INC | $99.48 | 2024 | |
| Organon LLC | $85.41 | 2022-2024 | Nexplanon, Nuvaring |
| Myovant Sciences INC. | $57.84 | 2022 | |
| Biogen, INC. | $55.62 | 2024 | Zurzuvae |
| Becton, Dickinson and Company | $35.29 | 2022 | |
| Hologic Sales and Service, LLC | $33.41 | 2022-2025 | Myosure Tissue Removal Device, Novasure |
| Merck Sharp & Dohme LLC | $33.41 | 2024 | Gardasil 9, Gardasil |
| Abbvie INC. | $31.76 | 2023 | |
| Mayne Pharma Commercial LLC | $30.49 | 2022-2023 | |
| Sage Therapeutics, LLC | $24.48 | 2023 | |
| Sumitomo Pharma America, INC. | $22.47 | 2023 | Myfembree |
| Ethicon US, LLC | $20.76 | 2024 | Enseal X1 |
| Daiichi Sankyo INC. | $19.24 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.75 | 2023 | |
| Medtronic, INC. | $16.35 | 2024 | Venaseal |
| Medicem INC. | $13.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Teeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.